Stock 4174 OBI PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials OBI Pharma, Inc.

Equities

4174

TW0004174008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-12 EDT 		5-day change 1st Jan Change
61.2 TWD -0.81% Intraday chart for OBI Pharma, Inc. -0.16% -11.82%
05-10 Obi Pharma, Inc. Announces the Termination of License Agreement with Odeon for the Rights of Obi-999 and Obi-833 in China, Hong Kong and Macau CI
03-26 OBI Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 27,095 24,833 26,213 22,680 15,831 15,910
Enterprise Value (EV) 1 23,492 20,460 22,738 20,319 11,352 13,675
P/E ratio -22.2 x -17 x -20 x -14.8 x -9.51 x -15.2 x
Yield - - - - - -
Capitalization / Revenue 2,031 x 28,478 x 186 x 1,208 x 3,361 x 383 x
EV / Revenue 1,761 x 23,463 x 161 x 1,082 x 2,410 x 329 x
EV / EBITDA -17.8 x -15.4 x -17.5 x -13 x -5.87 x -7.16 x
EV / FCF -45.4 x -33.2 x -29.5 x -20.3 x -8.08 x -11.1 x
FCF Yield -2.2% -3.01% -3.39% -4.93% -12.4% -8.98%
Price to Book 6.23 x 4.86 x 6.54 x 8.35 x 3.42 x 4.18 x
Nbr of stocks (in thousands) 173,129 188,129 188,586 198,948 229,109 229,248
Reference price 2 156.5 132.0 139.0 114.0 69.10 69.40
Announcement Date 3/27/19 3/24/20 3/30/21 3/25/22 3/15/23 3/26/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 13.34 0.872 140.9 18.77 4.711 41.55
EBITDA 1 -1,321 -1,329 -1,299 -1,559 -1,935 -1,911
EBIT 1 -1,428 -1,451 -1,466 -1,716 -2,123 -2,090
Operating Margin -10,703.07% -166,383.14% -1,040.47% -9,141.35% -45,059.69% -5,029.7%
Earnings before Tax (EBT) 1 -1,256 -1,445 -1,494 -1,742 -1,917 -1,276
Net income 1 -1,222 -1,407 -1,378 -1,531 -1,614 -1,046
Net margin -9,162.92% -161,356.19% -978.05% -8,154.1% -34,258.46% -2,518.65%
EPS 2 -7.062 -7.759 -6.939 -7.694 -7.266 -4.569
Free Cash Flow 1 -518 -615.7 -770.4 -1,002 -1,406 -1,228
FCF margin -3,883% -70,607.53% -546.83% -5,336.49% -29,835.87% -2,955.48%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/27/19 3/24/20 3/30/21 3/25/22 3/15/23 3/26/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 3,603 4,373 3,476 2,361 4,479 2,235
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -518 -616 -770 -1,002 -1,406 -1,228
ROE (net income / shareholders' equity) -26.2% -29.8% -27.7% -39.5% -38% -22.8%
ROA (Net income/ Total Assets) -18% -17.5% -15.5% -21.8% -23.9% -21.3%
Assets 1 6,780 8,047 8,894 7,012 6,764 4,902
Book Value Per Share 2 25.10 27.10 21.30 13.70 20.20 16.60
Cash Flow per Share 2 21.20 24.20 16.80 12.60 20.70 3.920
Capex 1 20.1 48 183 241 255 102
Capex / Sales 151.04% 5,503.44% 129.67% 1,285.56% 5,405.43% 245.33%
Announcement Date 3/27/19 3/24/20 3/30/21 3/25/22 3/15/23 3/26/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
OBI PHARMA, INC. Stock OBI Pharma, Inc.
-11.82% 433M
MODERNA, INC. Stock Moderna, Inc.
+26.37% 48.16B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.01% 41.73B
LONZA GROUP AG Stock Lonza Group AG
+46.00% 41.03B
CELLTRION, INC. Stock Celltrion, Inc.
-5.31% 28.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.34% 25.59B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.69% 18.96B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+6.23% 12.92B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.99% 12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.38% 11.77B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 4174 Stock
  4. Financials OBI Pharma, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW